Skip to main content

MoneyWorks4Me

GlaxoSmithKline Pharmaceuticals informs about board meeting

04 May 2016 Evaluate

GlaxoSmithKline Pharmaceuticals has informed that a meeting of the Board of Directors of the Company will be held on May 25, 2016, to consider, approval of audited financial results (Standalone & Consolidated) for the quarter / year ended March 31, 2016 and to recommend dividend, if any, on the equity shares of the Company.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1866.95
Dr. Reddys Labs. 1380.00
Cipla 1394.00
Lupin 1972.50
Zydus Lifesciences 1189.00
View more..